ATE78160T1 - Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien. - Google Patents

Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.

Info

Publication number
ATE78160T1
ATE78160T1 AT86400867T AT86400867T ATE78160T1 AT E78160 T1 ATE78160 T1 AT E78160T1 AT 86400867 T AT86400867 T AT 86400867T AT 86400867 T AT86400867 T AT 86400867T AT E78160 T1 ATE78160 T1 AT E78160T1
Authority
AT
Austria
Prior art keywords
naftidrofuryl
treat neuropathies
neuropathies
treat
furanpro
Prior art date
Application number
AT86400867T
Other languages
English (en)
Inventor
Michel Mosnier
Marcel Grand
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Application granted granted Critical
Publication of ATE78160T1 publication Critical patent/ATE78160T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AT86400867T 1985-04-23 1986-04-22 Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien. ATE78160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506132A FR2580502B1 (fr) 1985-04-23 1985-04-23 Emploi du " naftidrofuryl " dans la preparation d'un medicament
EP86400867A EP0202986B1 (de) 1985-04-23 1986-04-22 Verwendung von "Naftidrofuryl" zur Behandlung von Neuropathien

Publications (1)

Publication Number Publication Date
ATE78160T1 true ATE78160T1 (de) 1992-08-15

Family

ID=9318551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86400867T ATE78160T1 (de) 1985-04-23 1986-04-22 Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.

Country Status (7)

Country Link
US (1) US4652583A (de)
EP (1) EP0202986B1 (de)
JP (1) JPH064535B2 (de)
AT (1) ATE78160T1 (de)
DE (1) DE3685988T2 (de)
FR (1) FR2580502B1 (de)
IE (1) IE59047B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440928B1 (en) * 1988-12-06 2002-08-27 Colorado State University Research Foundation Method for treating diabetic neuropathy with NGF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL274986A (de) * 1961-02-23
US3445574A (en) * 1962-09-20 1969-05-20 Lipha Compositions and method for arresting spasms with the diethylaminoethyl ester of beta-(1-naphthyl)-beta'-tetrahydrofurylisobutyric acid
NL142872C (de) * 1963-03-28
FR3843M (fr) * 1964-03-17 1966-01-17 Lipha Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.
FR2505836A1 (fr) * 1981-05-14 1982-11-19 Sanofi Sa Citrate de naftidrofuryl et son application therapeutique

Also Published As

Publication number Publication date
EP0202986A3 (en) 1990-05-16
JPS61249921A (ja) 1986-11-07
US4652583A (en) 1987-03-24
FR2580502A1 (fr) 1986-10-24
FR2580502B1 (fr) 1988-07-08
DE3685988T2 (de) 1993-02-04
JPH064535B2 (ja) 1994-01-19
DE3685988D1 (de) 1992-08-20
EP0202986A2 (de) 1986-11-26
EP0202986B1 (de) 1992-07-15
IE59047B1 (en) 1993-12-15
IE860892L (en) 1986-10-23

Similar Documents

Publication Publication Date Title
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
AU8091787A (en) The use of paroxetine to treat pain
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
BR9007115A (pt) Novo trombolitico
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
ATE78160T1 (de) Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE3584426D1 (de) Verwendung von spergualin oder eines seiner pharmazeutisch akzeptablen salze zur herstellung eines transplantation-immunitaet unterdrueckenden und anti-allergischen mittels.
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time